Squalene

DB11460ApprovedInvestigationalVet approvedWithdrawnSmall molecule

Squalene is originally obtained from shark liver oil. It is a natural 30-carbon isoprenoid compound and intermediate metabolite in the synthesis of cholesterol. It is not susceptible to lipid peroxidation... It is ubiquitously distributed in human tissues where it is transported in serum generally in association with very low density lipoproteins.

Chemical structure of Squalene
Formula / weight
C30H50 · 410.73 g/mol (avg)
Also known as
Spinacene · Supraene

Resolves to

Compound
UNII7QWM220FJHCAS111-02-4ChEMBLCHEMBL458402ChEBI15440PubChem638072KEGGC00751
Clinical / RWD
RxNorm10014
Structure
InChIKeyYYGNTYWPHWGJRM-AAJYLUCBSA-NSMILESCC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C
Targets
O76054SEC14L2

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
7Marketed productsAcross 2 countries and 4 labellers
Sign in
20+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Squalene, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In